Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611087 · ClinicalTrials.gov registry record
Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants
A clinical trial of Obesity-Related Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 39
- Enrollment target
- 1
- Study location
NCT04611087: Recruiting study of Obesity-Related Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04611087 is a study of Obesity-Related Malignant Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 39 participants, below the 252-participant average among 6 other Obesity-Related Malignant Neoplasm trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04611087, a study of Obesity-Related Malignant Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates how individuals feel about a dietary mobile application. Information collected from focus groups and interviews may help doctors and mobile application developers to determine preferences and participant feedback about the appeal and usefulness of a mobile application.
Primary Outcome
Thematic and narrative analyses will be conducted from the transcriptions to gain an understanding for the preferences of food and beverage self-monitoring methodology and respective feedback messages.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Interview
- BEHAVIORAL Discussion
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-07-03 |
| Est. Completion | 2027-04-30 |
What NCT04611087 shows while recruiting
NCT04611087 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 252-participant average among 6 other Obesity-Related Malignant Neoplasm trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Obesity-Related Malignant Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT04611087 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04611087 about?
NCT04611087 is a clinical study titled "Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants". This study investigates how individuals feel about a dietary mobile application. Information collected from focus groups and interviews may help doctors and mobile application developers to determine preferences and participant feedback about the appeal and usefulness of a mobile application.
What is the current status of trial NCT04611087?
This trial is currently recruiting. The enrollment target is 39 participants. The study started on 2018-07-03. Estimated completion is 2027-04-30.
What conditions does trial NCT04611087 study?
This clinical trial studies the following conditions: Obesity-Related Malignant Neoplasm.
What interventions are being tested in trial NCT04611087?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Discussion (BEHAVIORAL).
Who is sponsoring clinical trial NCT04611087?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04611087 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity-Related Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women
RECRUITING · NA
-
Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families
ACTIVE NOT RECRUITING · NA
-
Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families
ACTIVE NOT RECRUITING · NA
-
A Sugar-Sweetened Beverage Reduction Intervention for Native American Men
ACTIVE NOT RECRUITING · NA
-
Telephone Delivered Weight Loss, Nutrition, Exercise WeLNES Study
ACTIVE NOT RECRUITING · Phase 3
-
Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI